CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statements on Forms S-8 No. 333-42533, No. 333-86001, No. 333-62734 and No. 333-100011 (pertaining to the 1995 Stock Option Plan and the 1998 Stock Option Plan, as amended and restated, and the 2002 Stock Option Plan), and Forms S-3 No. 333-33710, No. 333-51250, No. 333-53538 and No. 333-112513 of Titan Pharmaceuticals, Inc. of our report dated February 20, 2004 with respect to the consolidated financial statements of Titan Pharmaceuticals, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2003.
/s/ Ernst & Young LLP
Palo
Alto, California
March 10, 2004